ChemBriefSQM Earnings Jump on Strong Gains in Lithium Business
SQM reported a 646% surge in Q2 net income driven by rising lithium prices and demand, projecting over 2.1 million metric tons of global lithium demand by 2026.
chemweek · 2026-08-20 05:45 UTC
SQM reported a 646% surge in Q2 net income driven by rising lithium prices and demand, projecting over 2.1 million metric tons of global lithium demand by 2026.
Sociedad Química y Minera de Chile (SQM) announced doubling its Mt Holland lithium project output to 760,000 tonnes annually with a $450-500 million investment. The expansion includes an ore sorting f
SQM shares dropped 1.34% while analysts maintained a 'Hold' rating with an $85 target price. The company supplies lithium and specialty chemicals for agriculture, batteries, and pharmaceuticals.
SQM maintains a 6.88 earnings forecast score with a 'Hold' rating and $65 price target. Next quarter revenue is projected at $2.26 billion with an EPS of $2.06.
SQM shares rose over 3% after Scotiabank reiterated a bullish outlook, citing strong lithium demand and low production costs. The bank maintained a $105 price target, noting potential capacity expansi
SQM reported Q1 net income of $364.7 million, driven by 70% revenue growth in lithium and other segments. Management anticipates continued tight supply-demand dynamics and potential price hikes in the
SQM reported adjusted Ebitda of $837 million and raised its lithium sales volume forecast to grow 15% this year, driven by strong demand from battery storage systems and electric vehicles.
Sociedad Química y Minera de Chile shares rose 31.4% year-to-date, sparking valuation debates amidst strong lithium pricing. Analysts remain divided between bullish sentiment and risks from Chile's re
SQM announced a quarterly cash dividend of $0.6692 per share, reflecting management confidence while balancing lithium expansion capex. Future investment narratives depend heavily on lithium pricing a
SQM reported rising earnings driven by stronger lithium pricing and demand, though adjusted earnings fell short of analyst estimates.
Elkem reported a 14% sales drop in Q4 due to pricing pressures, citing continued uncertainty while maintaining focus on capital discipline.